Cyberounds Logo
September 26, 2020 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Age-related Macular Degeneration (AMD)
CME credit is no longer available for this conference.
Leon Charkoudian, M.D., and Joshua L. Dunaief, M.D., Ph.D.

Dr. Charkoudian is a resident and Dr. Dunaief is Assistant Professor of Ophthalmology, F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA.

Within the past 12 months, Drs. Charkoudian and Dunaief report no conflicts of interest.

Albert Einstein College of Medicine, CCME staff and interMDnet staff have nothing to disclose.


Release Date: 10/27/2008
Termination Date: 10/27/2010

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Describe the basics and natural history of age-related macular degeneration
  • Identify who should be screened for age-related macular degeneration and when a patient should be referred for further evaluation
  • Discuss the treatments available for age-related macular degeneration.

 
The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity